Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-13 Option Award | 2024-05-15 4:18 pm | N/A N/A | INSMED Inc | INSM | Desjardins Clarissa Director | 13,162 | $0 | 61,949 (Direct) | View |
| 2023-05-11 Option Award | 2023-05-15 4:22 pm | N/A N/A | INSMED Inc | INSM | Desjardins Clarissa Director | 13,192 | $0 | 48,787 (Direct) | View |
| 2022-05-11 Option Award | 2022-05-13 6:16 pm | N/A N/A | INSMED Inc | INSM | Desjardins Clarissa Director | 14,645 | $0 | 35,595 (Direct) | View |
| 2021-05-12 Option Award | 2021-05-14 4:24 pm | N/A N/A | INSMED Inc | INSM | Desjardins Clarissa Director | 7,558 | $0 | 20,950 (Direct) | View |
| 2020-06-01 Option Award | 2020-06-02 4:58 pm | N/A 2030-05-31 | Xenon Pharmaceuticals Inc. | XENE | Desjardins Clarissa Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2020-05-12 Option Award | 2020-05-14 8:59 pm | N/A N/A | INSMED Inc | INSM | Desjardins Clarissa Director | 8,097 | $0 | 13,392 (Direct) | View |
| 2020-01-13 Option Award | 2020-01-14 2:34 pm | N/A 2030-01-12 | Xenon Pharmaceuticals Inc. | XENE | Desjardins Clarissa Director | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2020-01-14 2:24 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | Desjardins Clarissa Director | 0 | $0 | 0 (Direct) | View |